Australia wants tougher premarket scrutiny for higher-risk devices; lower-risk product rules to be relaxed
This article was originally published in Clinica
Executive Summary
Australia's Therapeutic Goods Administration is proposing to increase its scrutiny of EU conformity assessment certificates for medical devices by broadening the list of products that will require a mandatory application audit by the agency to include implantable devices and surgically invasive devices intended for long-term use.